The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension
Hypertension

About this trial
This is an interventional basic science trial for Hypertension focused on measuring Hypertension, blood pressure, Aldosterone, Eplerenone, Amlodipine, Primary aldosteronism, Exercise pressor reflex, handgrip exercise, passive arm cycling, active arm cycling
Eligibility Criteria
Inclusion Criteria:
- Experiments will be performed on 3 groups of nondiabetic human subjects:
- 1) stage I (140-159/90-99 mmHg) subjects with essential hypertension.
- 2) stage I hypertensive subjects with primary aldosteronism
- 3) normotensive controls.
Exclusion Criteria:
- 1) Any evidence of cardiopulmonary disease, left ventricular hypertrophy or systolic dysfunction by echocardiography.
- 2) Blood pressure averaging ≥160/100 mmHg
- 3) Estimated glomerular filtration rate (eGFR) < 90 mL/min/1.73m2
- 4) Diabetes mellitus or other systemic illness
- 5) Pregnancy
- 6) Hypersensitivity to nitroprusside, phenylephrine, amlodipine or eplerenone
- 7) Any history of substance abuse or current cigarette use
- 8) Any history of psychiatric illness
- 9) History of malignancy
Sites / Locations
- UT Southwestern Medical Center
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Initial treatment with Amlodipine
Initial treatment with Eplerenone
The subject will be started on Amlodipine 2.5-10 mg daily, which he or she will continue for a period of 12 weeks. Following the 12-week treatment period, the procedures listed below will be performed. After completion of the study procedures, the medication will be discontinued. The subject will be started on Eplerenone 50 - 200 mg daily, which he or she will continue for a period of 8 weeks. Following the 8 week treatment period, the procedures listed below will be performed. After completion of the study procedures, the medication will be discontinued.
The subject will be started on Eplerenone 50 - 200 mg daily, which he or she will continue for a period of 12 weeks. Following the 12-week treatment period, the procedures listed below will be performed. After completion of the study procedures, the medication will be discontinued. The subject will be started on Amlodipine 2.5-10 mg daily, which he or she will continue for a period of 8 weeks. Following the 8 week treatment period, the procedures listed below will be performed. After completion of the study procedures, the medication will be discontinued.